AT

Awanish Trivesh Singh

Active Director Director DIN 11645535
DIN 11645535 First appointment Apr 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Awanish Trivesh Singh

Data last updated:

Awanish Trivesh Singh is a Director at Advix Pharma Private Limited (since 2026).

DIN 11645535
Primary Designation Director
First Appointment 02 Apr 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Advix Pharma Private Limited U46497MR2026PTC475258
Director02 Apr 20262026Active

Board colleagues of Awanish Trivesh Singh

NameDINCompanyDesignation
Surekha Kashinath Rokade11645536Advix Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Advix Pharma Private Limited
Premium access

Shareholding and investment profile for Awanish Trivesh Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Awanish Trivesh Singh

Awanish Trivesh Singh currently holds 1 directorship: Advix Pharma Private Limited (Director, since 02 Apr 2026).

Awanish Trivesh Singh was first appointed on 02 Apr 2026 as Director at Advix Pharma Private Limited.

The current boards of Awanish Trivesh Singh's companies include Surekha Kashinath Rokade (Advix Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available